LifeStance Health (LFST) Cash from Financing Activities (2020 - 2026)

LifeStance Health has disclosed Cash from Financing Activities across 7 years of filings, most recently posting -$73.0 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities fell 632.26% year-over-year to -$73.0 million; the TTM figure through Mar 2026 stood at -$79.0 million (down 351.79% YoY), while the FY2025 annual figure was -$16.0 million, down 60.4% from the prior year.
• Cash from Financing Activities eased to -$73.0 million in Q1 2026, from -$1.9 million in the prior quarter.
• Over the last five years, Cash from Financing Activities for LFST reached as high as $30.8 million in Q4 2023 and fell as low as -$73.0 million in Q1 2026.
• The 5-year median for Cash from Financing Activities is -$1.9 million (2025), against an average of -$250235.3.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities soared 183.49% — and 2026, when it slumped 632.26%.
• A 5-year view of Cash from Financing Activities shows it stood at $12.7 million in 2022, then jumped by 143.53% to $30.8 million in 2023, then sank by 113.16% to -$4.1 million in 2024, then surged by 52.94% to -$1.9 million in 2025, then slumped by 3724.24% to -$73.0 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$73.0 million, -$1.9 million, and -$2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.